DAFNA Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

DAFNA Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-376,993	Closed	-$10.4M	–	90
2021 Q2	$10.4M	Buy	376,993 +151,600	+67%	+$2.98M	2.17%	7
2021 Q1	$3.72M	Hold	225,393	–	–	0.88%	31
2020 Q4	$4.15M	Buy	225,393 +34,463	+18%	+$617K	1.24%	19
2020 Q3	$2.6M	Buy	+190,930	New	+$2.94M	0.84%	34
2020 Q1	–	Sell	-179,845	Closed	-$1.46M	–	89
2019 Q4	$1.46M	Sell	179,845 -184,384	-51%	-$1.7M	0.5%	48
2019 Q3	$3.61M	Buy	364,229 +185,923	+104%	+$1.76M	1.36%	24
2019 Q2	$2.25M	Buy	+178,306	New	+$1.88M	0.85%	32
2019 Q1	–	Sell	-228,939	Closed	-$1.72M	–	85
2018 Q4	$1.72M	Buy	228,939 +77,200	+51%	+$566K	0.85%	33
2018 Q3	$1.52M	Buy	151,739 +131,739	+659%	+$1.53M	0.62%	44
2018 Q2	$253K	Buy	+20,000	New	+$242K	0.12%	71

DAFNA Capital Management's TBIO Position: Q3 2021 in Review

DAFNA Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 376,993 shares — an estimated $10.4M sold.

DAFNA Capital Management first reported a position in TBIO in Q2 2018 and held it in 10 quarters. The position peaked at $10.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

DAFNA Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
DAFNA Capital Management sold 376,993 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $10.4M.
DAFNA Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
DAFNA Capital Management's Translate Bio, Inc. Common Stock position peaked at $10.4M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on DAFNA Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.